Skip to content

Chronic Unilateral Lumbar Radicular Pain

RecruitingNot applicableNCT06092749
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Chronic neuropathic lumbar pain is among one of the most widespread complaints of patients.Many approaches have been attempted to target chronic pain, with varying efficacy and risks. Transgrade (TG) epidural injection is a new technique using a Racz- Coudé needle for epidural access at a "transgrade" angle without requiring any specialized hardware or accessories. Interlaminar (IL) epidural steroid injection (ESI) is one of the procedures that involves the delivery of injectate to the epidural space through directing a needle between the laminae of two adjacent vertebrae.

Study details

Official title
Effectiveness of Transgrade vs Interlaminar Epidural Steroid Injection for Chronic Unilateral Lumbar Radicular Pain
Interventions
  • Other: Transgrade technique (TG)
  • Other: Interlaminar technique (IL)
Sponsor
Ain Shams University
Start date
2023-11-01
Primary completion
2026-10-31
Sex
All
Age range
from 21 Years
Results posted
No results posted in this snapshot
Countries
Egypt
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * \> 6-month history of persistent pain in one leg with back pain. * Capable of giving informed consent. * Unsatisfactory response to conventional treatments including physical therapy or medications with a numeric rating scale (NRS) ≥ 5. Exclusion Criteria: * Previous lumbar spinal surgery. * Myelopathy. * Rheumatoid disorders. * Psychiatric disorders * Bleeding or coagulation disorders

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06092749